OBJECT: The object was to study the value of postoperative positron emission tomography (PET) to assess the extension of brain tumor resection. METHODS: Twenty children operated on for total resection of a glial tumor (18 low-grade, 2 anaplastic) presented a signal on postoperative magnetic resonance (MR) images raising the question of a possible tumor residue. PET was performed early ((18)F-Fluoro-deoxyglucose in 1, (11)C-methionine in 16, both in 3) to further characterize the nature of the abnormal MR signal in order to consider second-look surgery. An increased tracer uptake found in 14 children led to reoperation on 11 of them, confirming the tumor histologically. No (11)C-methionine uptake led to a conservative attitude in 6 children in whom MR imaging follow-up showed no tumor progression. CONCLUSIONS: The early postoperative PET, especially with (11)C-methionine, appears to be a valid basis for complementary therapeutic decisions, especially second-look surgery, in glial tumors for which a radical resection is a key factor for prognosis.
OBJECT: The object was to study the value of postoperative positron emission tomography (PET) to assess the extension of brain tumor resection. METHODS: Twenty children operated on for total resection of a glial tumor (18 low-grade, 2 anaplastic) presented a signal on postoperative magnetic resonance (MR) images raising the question of a possible tumor residue. PET was performed early ((18)F-Fluoro-deoxyglucose in 1, (11)C-methionine in 16, both in 3) to further characterize the nature of the abnormal MR signal in order to consider second-look surgery. An increased tracer uptake found in 14 children led to reoperation on 11 of them, confirming the tumor histologically. No (11)C-methionine uptake led to a conservative attitude in 6 children in whom MR imaging follow-up showed no tumor progression. CONCLUSIONS: The early postoperative PET, especially with (11)C-methionine, appears to be a valid basis for complementary therapeutic decisions, especially second-look surgery, in glial tumors for which a radical resection is a key factor for prognosis.
Authors: J M Hoffman; M W Hanson; H S Friedman; B M Hockenberger; W J Oakes; E C Halperin; R E Coleman Journal: J Comput Assist Tomogr Date: 1992 Jan-Feb Impact factor: 1.826
Authors: M Levivier; D Wikier; S Goldman; P David; T Metens; N Massager; M Gerosa; D Devriendt; F Desmedt; S Simon; P Van Houtte; J Brotchi Journal: J Neurosurg Date: 2000-12 Impact factor: 5.115
Authors: D C Bowers; T P Krause; L J Aronson; A Barzi; P C Burger; B S Carson; J D Weingart; M D Wharam; E R Melhem; K J Cohen Journal: Pediatr Neurosurg Date: 2001-05 Impact factor: 1.162
Authors: W P Mason; A Grovas; S Halpern; I J Dunkel; J Garvin; G Heller; M Rosenblum; S Gardner; D Lyden; S Sands; D Puccetti; K Lindsley; T E Merchant; B O'Malley; L Bayer; M M Petriccione; J Allen; J L Finlay Journal: J Clin Oncol Date: 1998-01 Impact factor: 44.544
Authors: Arnold C Paulino; B-Chen Wen; John M Buatti; David H Hussey; Weining K Zhen; Nina A Mayr; Arnold H Menezes Journal: Am J Clin Oncol Date: 2002-04 Impact factor: 2.339
Authors: Benoit Pirotte; Serge Goldman; Sacha Salzberg; David Wikler; Philippe David; Arlette Vandesteene; Patrick Van Bogaert; Isabelle Salmon; Jacques Brotchi; Marc Levivier Journal: Pediatr Neurosurg Date: 2003-03 Impact factor: 1.162
Authors: Meri Utriainen; Liisa Metsähonkala; Toivo T Salmi; Tapio Utriainen; Hannu Kalimo; Helena Pihko; Anne Mäkipernaa; Arja Harila-Saari; Sirkku Jyrkkiö; Jukka Laine; Kjell Någren; Heikki Minn Journal: Cancer Date: 2002-09-15 Impact factor: 6.860
Authors: Lisbeth Marner; Michael Lundemann; Astrid Sehested; Karsten Nysom; Lise Borgwardt; René Mathiasen; Peder S Wehner; Otto M Henriksen; Carsten Thomsen; Jane Skjøth-Rasmussen; Helle Broholm; Olga Østrup; Julie L Forman; Liselotte Højgaard; Ian Law Journal: Neuro Oncol Date: 2021-12-01 Impact factor: 12.300